Current Research in Toxicology is a pioneering journal published by ELSEVIER that serves as a vital platform for disseminating cutting-edge research in the field of toxicology, spanning from biological impacts to pharmacological applications. With an ISSN of 2666-027X and an impressive Q2 ranking in key categories such as Applied Microbiology and Biotechnology, Health, Toxicology and Mutagenesis, and Toxicology, this journal underscores its commitment to high-quality research and significant contributions to the scientific community. Based in the Netherlands, Current Research in Toxicology aims to bridge the gap between academia and industry by providing rigorously peer-reviewed articles that cover a wide array of topics including novel methodologies, regulatory challenges, and emerging trends within the domain. The journal is accessible through various platforms, making it essential for researchers, professionals, and students eager to stay updated on the latest findings and advancements in toxicology. With a comprehensive focus on integrating theory with practical application, this journal is poised to influence future studies and policies in health and environmental science.

Journal of Toxicology, published by HINDAWI LTD, stands as a pivotal open-access journal in the fields of toxicology and pharmacology since its inception in 2009. With an ISSN of 1687-8191 and an E-ISSN of 1687-8205, this journal is dedicated to disseminating high-quality research that critically examines the effects of toxic substances on living organisms. Located in Egypt and operating from their London office, it aims to provide an extensive platform for researchers worldwide to share findings that can inform better practices in safety and regulation. As of 2023, it has achieved significant recognition, holding a Q3 ranking in both the pharmacology and toxicology categories, and is indexed in Scopus with noteworthy percentile rankings (Toxicology: 57th and Pharmacology: 55th). With a focus on innovative studies and emerging areas such as environmental toxicology, biomarker research, and therapeutic interventions, the Journal of Toxicology invites both experienced researchers and students to contribute, thereby enhancing the breadth and depth of toxicological knowledge for the global scientific community.

Particle and Fibre Toxicology is a leading open-access journal dedicated to advancing the field of toxicology, specifically focusing on the health impacts of particulate matter and fibers. Published by BMC since 2004, this journal operates from its offices in the United Kingdom and has gained significant recognition in the scientific community, achieving an impressive impact factor that highlights its relevance and influence. As indicated by its Q1 ranking in various categories including Health, Toxicology and Mutagenesis and Medicine (miscellaneous), it occupies a prestigious position in the academic landscape, appealing to researchers, professionals, and students alike. With a Scopus ranking of #4 in Toxicology and #7 in Environmental Science, the journal ensures high visibility and accessibility, providing a platform for the dissemination of key research findings and innovative methodologies in the interdisciplinary domains of toxicology. Through its commitment to open access, Particle and Fibre Toxicology fosters knowledge-sharing and collaboration, facilitating significant advancements in our understanding of the toxicological effects of environmental agents.

TOXICOLOGY MECHANISMS AND METHODS is a distinguished peer-reviewed journal dedicated to the advancement of toxicological research, published by Taylor & Francis Ltd. With its ISSN 1537-6516 and E-ISSN 1537-6524, this esteemed journal features critical studies and innovative methodologies in the field of toxicology, aligning with its mission to enhance understanding of biological mechanisms and risk assessment. The journal holds a commendable Q2 ranking in both the Health, Toxicology and Mutagenesis, and Toxicology categories, as well as strong positions in Scopus rankings, reflecting its influence with a 71st percentile rank in Toxicology and a 69th percentile rank in Environmental Health. Researchers, professionals, and students in the toxicology domain will find this journal to be an invaluable resource, offering open access options that foster widespread dissemination of its findings. Since its inception, encompassing converged years from 1991 to 1995 and from 2002 to 2024, the journal remains at the forefront of critical discourse and innovative research methods, making it a vital platform for advancing toxicological science globally.

Environmental Toxicology and Pharmacology, published by Elsevier, is a leading journal dedicated to advancing our understanding of the effects of environmental pollutants on biological systems. With an ISSN of 1382-6689 and an E-ISSN of 1872-7077, this journal covers a wide range of studies related to toxicology, pharmacology, and environmental health. The journal is classified as Q2 in key categories such as Health, Toxicology and Mutagenesis and Medicine (miscellaneous), and sits impressively in Q1 for Toxicology, reflecting its strong impact in the field. As of 2023, it ranks #30 out of 133 in Toxicology and #40 out of 148 in Health, indicating its high relevance and contribution to research. While the journal is not currently open access, it remains a pivotal resource for researchers, professionals, and students seeking to explore the intricacies of environmental health effects. Its commitment to publishing high-quality peer-reviewed research positions it as a crucial platform for scientific dialogue and discovery.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, published by WILEY, is a premier journal that serves as a vital resource for researchers, professionals, and students in the fields of pharmacology and physiology. With ISSN 0305-1870 and E-ISSN 1440-1681, this journal has established itself as a significant contributor to scientific dialogue since its inception in 1974. Currently spanning until 2024, it consistently publishes cutting-edge research addressing both experimental and clinical advancements in pharmacology and physiology. Recognized for its quality, it holds a Q2 ranking in the 2023 Pharmacology category and notable Q3 rankings in both Physiology and Medical Physiology. The journal's coverage of topical issues not only ensures a robust platform for innovative findings but also fosters collaborations across disciplines. Although not an Open Access journal, its curated content is invaluable for advancing knowledge, as evidenced by its solid Scopus rankings, which place it within the top percentiles of its field. Engaging with this journal means staying at the forefront of research that shapes clinical practices and experimental methodologies.

TOXICOLOGY LETTERS is a prominent journal dedicated to advancing the field of toxicology, providing a platform for high-quality research and reviews that explore the effects of chemical substances on biological systems. Published by Elsevier Ireland Ltd, this peer-reviewed journal has established itself as a vital resource in toxicological research since its inception in 1977, with a convergence of studies extending to 2024. With an impressive Scopus ranking, positioned at #28 out of 133 in the Toxicology category, TOXICOLOGY LETTERS garners a respectable percentile of 79, highlighting its significance in the academic community. Although it is not an open-access journal, its research is accessible through institutional subscriptions, ensuring that critical insights into human health and environmental safety are disseminated effectively. Being categorized in the Q2 quartile in both Medicine (miscellaneous) and Toxicology for 2023 further emphasizes its relevance and impact in these fields. This journal aims to foster collaboration between researchers and professionals, encouraging the exploration of innovative solutions to chemical hazards and the promotion of safer practices in pharmacology and toxicology.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, published by SPRINGER, is a pivotal journal in the fields of cell biology and developmental biology, focusing on in vitro studies that enhance our understanding of animal cellular mechanisms and development. With an ISSN of 1071-2690 and an E-ISSN of 1543-706X, this esteemed journal offers a platform for researchers to present their findings and contribute to the body of knowledge necessary for advancements in biological sciences. As a recognized publication, it holds a 2023 category quartile of Q4 in Cell Biology and Developmental Biology, and Q3 in miscellaneous Medicine, reflecting its competitive position yet inviting critical submissions that can span multidisciplinary approaches. Though currently not open access, it serves as an essential resource for professionals, researchers, and students dedicated to unraveling the complexities of cellular processes in an ever-evolving field. The journal has been continuously published since 1986, signifying its long-standing commitment to fostering scientific discourse and innovation.

FREE RADICAL RESEARCH, published by TAYLOR & FRANCIS LTD, stands at the forefront of studies in biochemistry and medicine, with a distinguished trajectory since its inception in 1985. This esteemed journal, which boasts an ISSN of 1071-5762 and an E-ISSN of 1029-2470, is recognized for its impactful contributions within the scientific community, as evidenced by its Q2 ranking in the 2023 category quartiles for both Biochemistry and miscellaneous Medicine. Utilizing rigorous peer-review standards, FREE RADICAL RESEARCH disseminates critical findings on the role of free radicals in biological systems, facilitating knowledge exchange among researchers, healthcare professionals, and students. Although it is not an open-access journal, its reach through academic databases ensures visibility and accessibility of groundbreaking research, making it an indispensable resource for those engaged in the dynamic fields of biochemistry and molecular biology. As the journal continues to evolve until 2024, it remains committed to advancing our understanding of oxidative stress and its implications for health and disease.

Drug Metabolism and Disposition is a premier journal published by the American Society for Pharmacology and Experimental Therapeutics, focusing on crucial advancements in the fields of pharmaceutical sciences and pharmacology. Since its inception in 1973, this esteemed journal has established itself as a leading platform for innovative research, earning a prestigious Q1 rating in both Pharmaceutical Science and Pharmacology categories as of 2023. With an impressive Scopus ranking of #52 out of 183 in Pharmaceutical Science and #105 out of 313 in Pharmacology, it occupies a vital place in an increasingly competitive academic landscape. Researchers, professionals, and students alike benefit from its rigorous peer-reviewed articles that delve into drug metabolism processes and their physiological implications, making it an indispensable resource for anyone aiming to advance their understanding of drug disposition and efficacy. This crucial journal contributes significantly to the ongoing dialogue in pharmacology and toxicology, providing insights that help shape future therapeutic strategies and regulatory policies.